Charite University Hospital, Berlin – Germany
About Prof. Dr. Thorsten Schlomm
Prof. Dr. Thorsten Schlomm is the W3 Professor of Urology and Clinic Director (Chairman) of the Department of Urology at Charité – Universitätsmedizin Berlin, Germany's most prestigious medical institution, since 2018. He completed his medical degree at Georg-August-Universität Göttingen and the University of Denver, USA, and received specialist clinical training at the Cleveland Clinic and Memorial Sloan Kettering Cancer Center, New York, USA. He has performed 3,000+ da Vinci robotic nerve-sparing radical prostatectomies and has ~696 scientific publications. He is Clinical Coordinator of the International Cancer Genome Consortium (ICGC) and The Cancer Genome Atlas (TCGA) for prostate cancer. The department is ranked by Focus magazine as one of Germany's best for prostate cancer treatment.
- 3,000+ da Vinci robotic nerve-sparing radical prostatectomies; ~696 scientific publications; W3 Professor & Chairman of Urology — Charité Berlin (2018–present)
- Medical degree — Göttingen & University of Denver, USA; specialist training at Cleveland Clinic (USA) and Memorial Sloan Kettering Cancer Center, New York, USA; Habilitation — UKE Hamburg (2009)
- Scientific Director — Martini-Klinik, UKE Hamburg (2010–2018); W3 Professor — UKE Hamburg (2011); Adjunct Professor of Molecular Urology — University of Bergen, Norway (2016–2017)
- Clinical Coordinator — ICGC (International Cancer Genome Consortium) & TCGA (The Cancer Genome Atlas) — prostate cancer research; Member — German, European (EAU), American (AUA) Societies of Urology, AACR
- EAU-certified Training Centre for Robotic Urological Surgery; part of Germany's largest Kidney Transplant Centre (Charité); ranked among Germany's best for prostate cancer (Focus magazine)
Qualifications & Credentials
Academic Degrees
- Medical Degree (Graduation) & Doctorate — Georg-August-Universität Göttingen and University of Denver, USA
- Specialist Training in Urology — University Hospitals of Göttingen and Hamburg
- Habilitation in Urology — University Hospital Hamburg-Eppendorf (UKE) — 2009 (Thesis: 'High throughput clinical validation of predictive and therapeutic biomarkers in prostate cancer using the tissue microarray (TMA) technique')
Fellowships & Special Training
- Clinical Specialisation in Prostate Cancer — Cleveland Clinic, Cleveland, Ohio, USA — 2007
- Clinical Specialisation in Prostate Cancer — Memorial Sloan Kettering Cancer Center, New York, USA — 2007
Certifications & Accreditations
- W3 Professor of Urology and Clinic Director — Charité – Universitätsmedizin Berlin (since 2018)
- W3 Professor of Urology — University Hospital Hamburg-Eppendorf (2011–2018)
- Adjunct Professor of Molecular Urology — Centre for Cancer Biomarkers CCBIO, University of Bergen, Norway (2016–2017)
- EAU-Certified Training Centre for Robotic Urological Surgery — Charité Department of Urology
- Member — Deutsche Gesellschaft für Urologie (DGU — German Society of Urology)
- Member — European Association of Urology (EAU)
- Member — American Urological Association (AUA)
- Member — American Association for Cancer Research (AACR)
Areas of Expertise
Major Conditions Treated
- Prostate Cancer (Radical Prostatectomy — Open & Robotic)
- Bladder Cancer (TURBT, Cystectomy)
- Kidney Cancer (Laparoscopic / Robotic Nephrectomy)
- Testicular Cancer
- Urethral Cancer
- Benign Prostatic Hyperplasia (BPH — ThuLEP, TURP, Laser)
- Kidney Transplantation (Germany's largest centre)
- Erectile Dysfunction & Male Infertility (Andrology)
- Paediatric Urology (Congenital Conditions)
Sub-specialties
- Robotic Nerve-Sparing Radical Prostatectomy (3,000+ Procedures): Internationally renowned expert in da Vinci robot-assisted nerve-sparing radical prostatectomy — 3,000+ procedures performed — with a particular focus on preserving potency (erectile function) while achieving optimal oncological clearance. Ranked by Focus magazine as one of Germany's best prostate cancer specialists, at an EAU-certified robotic surgery training centre.
- Precision Oncology & Molecular Urology (ICGC/TCGA Coordinator): Clinical Coordinator of both the International Cancer Genome Consortium (ICGC) and The Cancer Genome Atlas (TCGA) for prostate cancer — pioneering gene-based cancer therapy and individualised tumour genomic profiling — making Prof. Schlomm one of the world's foremost molecular uro-oncologists.
- Kidney Transplantation (Germany's Largest Centre): Charité's Department of Urology is part of Germany's largest Kidney Transplant Centre — performing nearly all living donor kidney removals via minimally invasive laparoscopic approaches — in collaboration with the departments of Nephrology and Surgery.
Advanced Procedures & Treatments
- da Vinci Robotic Nerve-Sparing Radical Prostatectomy (RALP)
- Open Radical Prostatectomy (Nerve-Sparing)
- TURP / ThuLEP / Greenlight Laser Prostatectomy (BPH)
- HIFU (High-Intensity Focused Ultrasound — Prostate Cancer)
- Robotic / Laparoscopic Nephrectomy (Kidney Cancer)
- TURBT (Transurethral Resection of Bladder Tumour)
- Radical Cystectomy (Bladder Cancer)
- Living Donor Laparoscopic Nephrectomy (Kidney Transplant)
- Gene-Based Cancer Therapy (Molecular Urology)
- mpMRI-Directed Prostate Biopsy
List of Disease and Treatment for which Prof. Dr. Thorsten Schlomm can be consulted
Professional Experience
Current Affiliation
- Charité – Universitätsmedizin Berlin, Department of Urology — W3 Professor of Urology & Clinic Director (Chairman), Campaigns Charité Mitte and Benjamin Franklin — since 2018
Past Affiliations
- Martini-Klinik (Prostate Cancer Centre), University Hospital Hamburg-Eppendorf (UKE) — Scientific Director — 2010–2018
- University Hospital Hamburg-Eppendorf (UKE) — Senior Physician / Scientific Director; W3 Professor of Urology (from 2011) — 2007–2018
- Memorial Sloan Kettering Cancer Center, New York, USA — Clinical Specialisation — 2007
- Cleveland Clinic, Cleveland, Ohio, USA — Clinical Specialisation — 2007
- University Hospital Hamburg-Eppendorf — Assistant Physician (Prostate Cancer Focus) — 2003–2007
- University of Bergen, Norway — Adjunct Professor of Molecular Urology (CCBIO) — 2016–2017
Key Achievements
- 3,000+ da Vinci robotic nerve-sparing radical prostatectomies performed
- ~696 scientific publications in urology and cancer research
- W3 Professor of Urology & Chairman — Charité – Universitätsmedizin Berlin (since 2018)
- Scientific Director — Martini-Klinik, UKE Hamburg (world-renowned prostate cancer centre) — 2010–2018
- Clinical Coordinator — ICGC & TCGA (prostate cancer)
- EAU-certified Robotic Urological Surgery Training Centre — established at Charité
- Ranked among Germany's best prostate cancer specialists — Focus magazine
- Numerous research awards in the field of prostate cancer; reviewer for national and international scientific journals
Awards & Recognitions
National & International Awards
- Numerous scientific research awards in the field of prostate cancer (specific titles not publicly listed individually)
- Ranked among Germany's best prostate cancer specialists — Focus magazine
Professional Memberships
- Deutsche Gesellschaft für Urologie (DGU)
- European Association of Urology (EAU)
- American Urological Association (AUA)
- American Association for Cancer Research (AACR)
Research & Publications
Selected Publications
- ~696 scientific publications in national and international peer-reviewed journals on prostate cancer, molecular urology, robotic surgery, and urological oncology.
- Clinical Coordinator — ICGC (International Cancer Genome Consortium) publications on prostate cancer genomics.
- Clinical Coordinator — TCGA (The Cancer Genome Atlas) prostate cancer data contributions.
- Habilitation Thesis: 'High throughput clinical validation of predictive and therapeutic biomarkers in prostate cancer using the tissue microarray (TMA) technique' — University Hospital Hamburg-Eppendorf — 2009.
Estimated Treatment Costs
| Procedure / Consultation | Estimated Cost (EUR) | Estimated Cost (USD) |
|---|---|---|
| Urology / Prostate Cancer Consultation | €200 – €400 | $220 – $440 |
| da Vinci Robotic Radical Prostatectomy (RALP) | €12,000 – €25,000 | $13,200 – $27,500 |
| HIFU (Prostate Cancer) | €8,000 – €18,000 | $8,800 – $19,800 |
| TURP / ThuLEP / Laser Prostatectomy (BPH) | €5,000 – €12,000 | $5,500 – $13,200 |
| Living Donor Laparoscopic Nephrectomy (Kidney Transplant) | €15,000 – €30,000 | $16,500 – $33,000 |
*Indicative estimates only. Actual costs subject to hospital pricing, case complexity, and insurance. Contact Cancer Rounds for a personalised quote.
Frequently Asked Questions
1. What advanced technologies does Prof. Dr. Thorsten Schlomm use in Urology and Uro-Oncology treatment?
Prof. Dr. Thorsten Schlomm — W3 Professor at Charité Berlin, 3,000+ da Vinci robotic nerve-sparing prostatectomies, Clinical Coordinator of ICGC and TCGA, trained at Cleveland Clinic and Memorial Sloan Kettering — uses da Vinci robotic RALP, open nerve-sparing radical prostatectomy, HIFU, ThuLEP/Laser/TURP, mpMRI-directed biopsy, gene-based precision oncology, and laparoscopic donor nephrectomy at the EAU-certified robotic surgery training centre at Charité – Universitätsmedizin Berlin.
2. What conditions does Prof. Dr. Thorsten Schlomm specialise in treating?
Prof. Dr. Schlomm specialises in urology and uro-oncology — treating prostate cancer, bladder cancer, kidney cancer, testicular cancer, urethral cancer, BPH, kidney transplantation, and andrological conditions — for patients seeking Germany's most eminent prostate cancer and robotic urology specialist at Charité Hospital Berlin.
3. How do I book an appointment with Prof. Dr. Thorsten Schlomm?
Appointments with Prof. Dr. Thorsten Schlomm can be booked directly through the Cancer Rounds website or by contacting their international patient department for priority scheduling.
4. Can international patients receive treatment from Prof. Dr. Thorsten Schlomm?
Yes. Cancer Rounds provides full assistance for international patients seeking treatment from Prof. Dr. Thorsten Schlomm, including medical visa invitation letters, airport transfers, and local accommodation coordination.
5. What support is available for international patients?
International patients benefit from a dedicated concierge service provided by Cancer Rounds, including language interpretation, financial counselling, and pre-travel virtual consultations to review medical records before arrival.
6. Does Prof. Dr. Thorsten Schlomm offer second opinions for Urology and Uro-Oncology cases?
Yes. Second opinion consultations can be arranged via Cancer Rounds for patients seeking expert Urology and Uro-Oncology review from a specialist in Berlin.
Charite University Hospital, Berlin - Germany
